NCT06991556 2026-05-01An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)NovartisPhase 2 Recruiting150 enrolled